E. coli NF73-1 Isolated From NASH Patients Aggravates NAFLD in Mice by Translocating Into the Liver and Stimulating M1 Polarization

Yifan Zhang, Weiwei Jiang, Jun Xu, Na Wu, Yang Wang, Tianyu Lin, Yun Liu, Yulan LiuFrontiers in Cellular and Infection Microbiology 2020 · DOI

Abstract

E. coli NF73-1 is a critical trigger in the progression of nonalcoholic fatty liver disease (NAFLD). This study suggests that E. coli NF73-1 might be a specific strain prevalent in NAFLD patients, driving disease progression through gut-to-liver translocation and immune activation.

Introduction

Nonalcoholic fatty liver disease (NAFLD) and its more severe form, nonalcoholic steatohepatitis (NASH), are global health crises linked to obesity and metabolic syndrome. While the "gut-liver axis" is known to play a role in metabolic health, identifying specific bacterial drivers has remained a challenge. This paper identifies a specific bacterial culprit—Escherichia coli strain NF73-1—and elucidates the molecular pathway it uses to damage the liver by exploiting a weakened intestinal barrier to trigger hepatic inflammation.

Human Profiling and Strain Identification

The researchers began by analyzing intestinal mucosal samples from healthy controls (HC), NAFLD patients, and NASH patients using 16S rRNA sequencing. They observed a significant enrichment of the genus Escherichia in patients with liver disease compared to healthy individuals.

Relative abundance of Escherichia in healthy controls (HC), NAFLD, and NASH patients.

From a NASH patient, the team isolated a specific strain, E. coli NF73-1. Whole-genome sequencing (WGS) and comparative genomics revealed that NF73-1 possesses a unique repertoire of virulence factors, including genes related to adhesion and invasion (such as fimH and ybt) that are largely absent in standard non-pathogenic laboratory strains like MG1655. This genomic profile explains why this specific strain is uniquely linked to the progression of NASH.

Comparative genomic analysis of virulence factors between E. coli NF73-1 and the laboratory strain MG1655.

Experimental Results

To determine the causal role of NF73-1, the researchers utilized antibiotic-depleted mouse models fed either a normal diet (ND) or a high-fat diet (HFD).

Gut-to-Liver Translocation

Using EGFP-labeled bacteria, the study demonstrated that NF73-1 translocates from the gut to the liver specifically in mice fed a high-fat diet. This suggests that the diet "opens the door" by damaging the intestinal barrier, allowing NF73-1 to enter the portal circulation and reach the liver.

Hepatic Inflammation and the Metabolic Switch

Once in the liver, NF73-1 triggers M1 macrophage polarization via the TLR2/NLRP3 signaling pathway. These pro-inflammatory macrophages then signal hepatocytes through the mTOR-SREBP-1 pathway to stop burning fat and start synthesizing it. Mice colonized with NF73-1 showed significantly higher NAFLD Activity Scores (NAS), increased liver weight, and elevated ALT/AST levels, which are clinical markers of liver damage.

Discussion and Conclusion

This study identifies E. coli NF73-1 as a critical trigger in NAFLD progression. The findings highlight that the metabolic switch toward fat synthesis is driven by specific bacterial-induced inflammation, which is facilitated by a high-fat diet's impact on gut permeability. Future work may focus on targeting this specific strain through narrow-spectrum antibiotics, phages, or targeted probiotics as a viable treatment for NASH patients who harbor high levels of NF73-1.

Summary updated

Abstract

<i>E. coli</i> NF73-1 is a critical trigger in the progression of NAFLD. <i>E. coli</i> NF73-1 might be a specific strain for NAFLD patients.
BibTeX
@inproceedings{zhang2020e,
  author = {Yifan Zhang and Weiwei Jiang and Jun Xu and Na Wu and Yang Wang and Tianyu Lin and Yun Liu and Yulan Liu and Yulan Liu and Yulan Liu},
  title = {{E. coli NF73-1 Isolated From NASH Patients Aggravates NAFLD in Mice by Translocating Into the Liver and Stimulating M1 Polarization}},
  booktitle = {Frontiers in Cellular and Infection Microbiology},
  year = {2020},
  doi = {10.3389/fcimb.2020.535940},
}
Figure